TELA Bio, Inc. - Common stock — 재무제표 (NASDAQ:TELA) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 86.46 M62.54 M67.86 M78.05 M86.57 M81.42 M 총 부채 37.43 M42.45 M53.55 M59.17 M58.11 M75.11 M 자본금 총액 49.03 M20.1 M14.3 M18.88 M28.46 M6.31 M 총 부채 및 주주자본 86.46 M62.54 M67.86 M78.05 M86.57 M81.42 M 총부채 ——39.92 M40.52 M41.12 M55.65 M 순부채 ——39.92 M40.52 M41.12 M4.81 M

뉴스

TELA Bio, Inc. (TELA) Reports Q1 Loss, Beats Revenue Estimates

AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Beats Revenue Estimates

BridgeBio Pharma (BBIO) Reports Q1 Loss, Tops Revenue Estimates

TELA Bio Analysts Cut Their Forecasts After Q4 Results - TELA Bio (NASDAQ:TELA)

TELA Bio, Inc. (TELA) Q4 2025 Earnings Call Transcript

TELA Bio, Inc. (TELA) Reports Q4 Loss, Lags Revenue Estimates

Assembly Biosciences (ASMB) Q4 Earnings and Revenues Top Estimates

Astrana Health, Inc. (ASTH) Q4 Earnings and Revenues Surpass Estimates

Anika Therapeutics (ANIK) Q4 Earnings and Revenues Beat Estimates

텔레콤 오스트리아 2025년 4분기 실적: 해외 시장이 3% 매출 성장 견인

Small Medtech TELA Bio Takes On Becton Dickinson, Alleges Hernia Mesh Monopoly - Becton Dickinson (NYSE:BDX), TELA Bio (NASDAQ:TELA)

TELA Bio 목표가, Lake Street, 판매 문제로 $3로 하향